What's happening
This bill requires prescribers or pharmacists to notify patients, both in writing and orally, when switching generic drug products.
Why it matters
Enhances patient awareness and consent. By mandating both written and oral notification of generic drug switches, the bill empowers patients to be fully informed about changes to their medication, reducing confusion and potential health risks from unexpected substitutions.
Improves safety and trust in medication management. Patients can better track their treatments and identify possible side effects or efficacy issues related to specific generic products, strengthening communication between patients and healthcare professionals.
Addresses issues of drug variability. Not all generic drugs are identical in inactive ingredients or manufacturer; this bill acknowledges potential differences that can affect patient outcomes, especially for those sensitive to formulation changes.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Notify Patients on Drug Switches
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to higher education
- Referred to higher education
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
3669
2017-2018 Regular Sessions
IN ASSEMBLY
January 30, 2017
Introduced by M. of A. CYMBROWITZ -- read once and referred to the Committee on Higher Education
AN ACT to amend the education law, in relation to notification of the substitution of one generic drug product for another generic drug
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 6 of section 6810 of the education law is amended by adding a new paragraph (b-1) to read as follows:
(b-1) The prescriber or pharmacist shall inform the patient whether he or she has prescribed or substituted a different generic drug product from the generic drug product the patient has previously received. Notification required pursuant to this paragraph shall be provided both written and orally.
§ 2. This act shall take effect on the ninetieth day after it shall have become a law.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD06956-01-7
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.